Shares of California Nanotechnologies Corp. (CANOF) surged 12.2% to $0.31 on October 27 after the company reported second-quarter fiscal 2027 results showing accelerating revenue and a hefty pipeline of incoming orders. For a company with a market capitalization measured in the low single-digit millions, the question isn't whether the growth is real — it's whether it's enough to close the gap between promise and profitability. Cal Nano's Revenue Streak and $2.5 Million Order Pipeline Look Promising — But Does a $359K Loss and Shrinking Margins Signal the Growth Is Costing Too Much?
Shares surged 12.2% to $0.31 after California Nanotechnologies, a roughly 20-person outfit that makes specialty components for nuclear reactors and other advanced applications, posted its second straight quarter of double-digit revenue growth. The real headline, though, may be a forward-looking one: a $2.5 million purchase-order haul already booked for the current quarter. For a company generating under $1 million per quarter, that figure could represent a step-change — if the margins hold up.
Two Quarters of Growth Show the Pivot to Nuclear Parts Is Working
Cal Nano reported revenue of US$956,794 for the quarter ended August 31, 2026, up 23% year over year. That follows Q1 revenue of US$917,854, which was up 28% from the prior year.
Fiscal 2026 was a rebuilding year after the company lost a "green steel" client that had represented 63% of revenue in FY2025.
Over the last twelve months, Cal Nano has repositioned itself as a domestic manufacturer of critical reactor components such as control rods and heat shielding. Back-to-back growth quarters suggest the nuclear-energy bet is gaining traction.
A $2.5 Million Order Book Dwarfs Recent Quarterly Sales
The company disclosed over $2.5 million in purchase orders already secured in Q3/FY2027, which it called evidence of "go-to-market success." If fulfilled in a single quarter, that would be roughly 2.6 times the Q2 run rate — a dramatic acceleration. Investors are clearly pricing in that potential, but execution at that scale is unproven for a sub-$5 million-revenue business.
Margins Are Moving the Wrong Way
Gross margin fell to 51% in the quarter from 62% a year earlier — an 1,100-basis-point decline.
Net loss was US$359,148 versus net income of $292,423 a year ago, driven by higher scale-up costs, unfavorable revenue mix, and the absence of a one-time warrant gain that had flattered the prior year.
Adjusted EBITDA — earnings before interest, taxes, depreciation, and amortization — improved 56% but was still negative at US$(36,786).
Liquidity Is Tight for a Company About to Scale
Cal Nano had approximately $1.0 million in cash as of October 27, with a $314,000 receivables payment expected by month's end. Fulfilling a $2.5 million order book will pressure working capital. Management expects margins to improve as fixed costs spread over a larger revenue base , but until that inflection arrives, investors are betting on a promise, not a profit.